- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01173250
Is Diverting Ileostomy Necessary in Stapled Ileoanal Pouch?
August 13, 2010 updated by: Mansoura University
Total proctocolectomy with ileal pouch anal anastomosis is the first choice surgical operation for management of ulcerative colitis and familial adenomatous polyposis.
The addition of diverting ileostomy may reduce septic complications.
In this randomized study the investigators compare two groups of patients with stapled ileoanal pouch one of them had diverting ileostomy and in the other this step is omitted.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients having total proctocolectomy with ileal pouch anal anastomosis.
Exclusion Criteria:
- hypoalbuminemia
- prolonged steroid use
- anemia
- anastomosis under tension
- leak with air test
- bleeding
- poor vascular supply of anastomosis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: stapled ileoanal pouch without diverting ileostomy
|
|
Placebo Comparator: stapled ileoanal pouch with diverting ileostomy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
July 30, 2010
First Submitted That Met QC Criteria
July 30, 2010
First Posted (Estimate)
August 2, 2010
Study Record Updates
Last Update Posted (Estimate)
August 16, 2010
Last Update Submitted That Met QC Criteria
August 13, 2010
Last Verified
October 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Neoplasms by Histologic Type
- Neoplasms
- Neoplasms by Site
- Neoplasms, Glandular and Epithelial
- Gastrointestinal Neoplasms
- Digestive System Neoplasms
- Gastrointestinal Diseases
- Genetic Diseases, Inborn
- Colonic Diseases
- Intestinal Diseases
- Intestinal Neoplasms
- Colorectal Neoplasms
- Neoplastic Syndromes, Hereditary
- Adenomatous Polyps
- Adenoma
- Intestinal Polyposis
- Adenomatous Polyposis Coli
Other Study ID Numbers
- 251068
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ulcerative Colitis
-
Ferring PharmaceuticalsCompletedActive Ulcerative Colitis | Remission of Ulcerative ColitisCanada
-
Palatin Technologies, IncRecruitingUlcerative Colitis | Ulcerative Colitis Flare | Ulcerative Colitis Acute | UlcerativeUnited States
-
Theravance BiopharmaCompletedUlcerative Colitis, Active Severe | Ulcerative Colitis, Active ModerateUnited States, Georgia, Moldova, Republic of, Romania
-
Rise Therapeutics LLCUniversity of Colorado, Denver; Mayo ClinicRecruitingUlcerative Colitis | Ulcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic | Ulcerative Colitis Chronic MildUnited States
-
Assistance Publique - Hôpitaux de ParisMRSU 938 - Research Center of Saint AntoineNot yet recruitingPediatric Ulcerative Colitis in RemissionFrance
-
Protagonist Therapeutics, Inc.CompletedUlcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic SevereUnited States, Austria, Bulgaria, Canada, Georgia, Germany, Hungary, Italy, Korea, Republic of, Poland, Russian Federation, Serbia, Ukraine
-
Theravance BiopharmaCompletedActive Mild Ulcerative Colitis, Active Moderate Ulcerative Colitis, Healthy SubjectsUnited States
-
Altheus Therapeutics, Inc.UnknownUlcerative Colitis | Left-sided Ulcerative Colitis | Distal Ulcerative ColitisUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...University Medical Center Groningen; UMC UtrechtRecruitingUlcerative Colitis | Ulcerative Colitis Flare | Ulcerative Colitis AcuteNetherlands
-
Immune PharmaceuticalsUnknownUlcerative Colitis, Active Severe | Ulcerative Colitis, Active ModerateIsrael
Clinical Trials on omitting diverting ileostomy
-
Daping Hospital and the Research Institute of Surgery...Not yet recruiting
-
Campus Bio-Medico UniversityCompletedIleostomy; Complications | Ileostomy - Stoma | Leakage, Anastomotic
-
University Hospital Inselspital, BerneTerminated
-
The First Hospital of Jilin UniversityNot yet recruitingFunctional Outcome | Diverting Ileostomy | Middle and Low Rectal Cancer | Stoma Complications
-
SafeHeal IncRecruitingColorectal Cancer | Stoma IleostomyUnited States
-
University Hospital, AngersUnknownEnterocolitis, Necrotizing | Intestinal Obstruction | Gastroschisis | Hirschsprung DiseaseFrance
-
fan liNot yet recruiting
-
University of Roma La SapienzaCompletedColo-rectal Anastomosis Dehiscence
-
Tel Aviv UniversityUnknown
-
Academisch Medisch Centrum - Universiteit van Amsterdam...ZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedHemorrhage | Blood Coagulation DisordersNetherlands